ADD3 and lung carcinoma: Although this screening method has its limitations, it could be a useful strategy to discover drugs that counteract dysregulated mRNA splicing patterns in lung cancer, using a similar construct with a NSCLC-specific cassette exon, such as e.g., from the NUMB, ADD3, or caspase-9 genes.